Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Skjøth-Rasmussen

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2022
Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [<sup>18</sup>F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastomaOtto M Henriksen, Adam E Hansen, Aida Muhic, et al.
Frontiers in Pediatrics|May 8, 2018
Importance of Comprehensive Molecular Profiling for Clinical Outcome in Children With Recurrent CancerOlga Østrup, Karsten Nysom, David Scheie, et al.
Neuro-Oncology|July 28, 2022
Genetic predisposition and evolutionary traces of pediatric cancer risk: a prospective 5-year population-based genome sequencing study of children with CNS tumorsUlrik Kristoffer Stoltze, Jon Foss-Skiftesvik, Thomas van Overeem Hansen, et al.
Acta Neuropathologica Communications|August 25, 2022
Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohortJon Foss-Skiftesvik, Ulrik Kristoffer Stoltze, Thomas van Overeem Hansen, et al.
Neuro-Oncology|June 26, 2018
VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenanceSigne R Michaelsen, Mikkel Staberg, Henriette Pedersen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2019
Early Postoperative <sup>18</sup>F-FET PET/MRI for Pediatric Brain and Spinal Cord TumorsLisbeth Marner, Karsten Nysom, Astrid Sehested, et al.
Acta Neurochirurgica|September 25, 2014
Predicting the "usefulness" of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European surveyWalter Stummer, Floriano Rodrigues, Philippe Schucht, et al.
Neuro-Oncology Advances|December 31, 2025
Dose-enhanced versus standard TTFields for first recurrence of glioblastoma: A randomized phase 2 clinical trialNikola Mikic, Slávka Lukacova, Jane Skjøth-Rasmussen, et al.
Acta Neurochirurgica|September 22, 2025
Postoperative speech impairment and cranial nerve deficits in children undergoing posterior fossa tumor surgery with intraoperative MRI - a prospective multinational studyAske Foldbjerg Laustsen, Jonathan Kjær Grønbæk, Radek Frič, et al.
Neurosurgical Review|August 19, 2022
Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient dataLasse Rehné Jensen, Andrea Daniela Maier, Atle Lomstein, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
European Journal of Nuclear Medicine and Molecular Imaging|July 30, 2022
Diagnostic yield of simultaneous dynamic contrast-enhanced magnetic resonance perfusion measurements and [<sup>18</sup>F]FET PET in patients with suspected recurrent anaplastic astrocytoma and glioblastomaOtto M Henriksen, Adam E Hansen, Aida Muhic, et al.
Frontiers in Pediatrics|May 8, 2018
Importance of Comprehensive Molecular Profiling for Clinical Outcome in Children With Recurrent CancerOlga Østrup, Karsten Nysom, David Scheie, et al.
Neuro-Oncology|July 28, 2022
Genetic predisposition and evolutionary traces of pediatric cancer risk: a prospective 5-year population-based genome sequencing study of children with CNS tumorsUlrik Kristoffer Stoltze, Jon Foss-Skiftesvik, Thomas van Overeem Hansen, et al.
Acta Neuropathologica Communications|August 25, 2022
Redefining germline predisposition in children with molecularly characterized ependymoma: a population-based 20-year cohortJon Foss-Skiftesvik, Ulrik Kristoffer Stoltze, Thomas van Overeem Hansen, et al.
Neuro-Oncology|June 26, 2018
VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenanceSigne R Michaelsen, Mikkel Staberg, Henriette Pedersen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2019
Early Postoperative <sup>18</sup>F-FET PET/MRI for Pediatric Brain and Spinal Cord TumorsLisbeth Marner, Karsten Nysom, Astrid Sehested, et al.
Acta Neurochirurgica|September 25, 2014
Predicting the "usefulness" of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European surveyWalter Stummer, Floriano Rodrigues, Philippe Schucht, et al.
Neuro-Oncology Advances|December 31, 2025
Dose-enhanced versus standard TTFields for first recurrence of glioblastoma: A randomized phase 2 clinical trialNikola Mikic, Slávka Lukacova, Jane Skjøth-Rasmussen, et al.
Acta Neurochirurgica|September 22, 2025
Postoperative speech impairment and cranial nerve deficits in children undergoing posterior fossa tumor surgery with intraoperative MRI - a prospective multinational studyAske Foldbjerg Laustsen, Jonathan Kjær Grønbæk, Radek Frič, et al.
Neurosurgical Review|August 19, 2022
Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient dataLasse Rehné Jensen, Andrea Daniela Maier, Atle Lomstein, et al.
Pageof 8